Prestige Consumer Healthcare Inc. (NYSE:PBH) Stake Lessened by Wellington Management Group LLP

Wellington Management Group LLP trimmed its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 74.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 22,604 shares of the company's stock after selling 65,354 shares during the period. Wellington Management Group LLP's holdings in Prestige Consumer Healthcare were worth $1,765,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its position in Prestige Consumer Healthcare by 3.1% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,624,501 shares of the company's stock valued at $126,274,000 after acquiring an additional 49,331 shares during the period. Geode Capital Management LLC lifted its stake in shares of Prestige Consumer Healthcare by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 1,348,745 shares of the company's stock valued at $105,342,000 after purchasing an additional 21,951 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth about $84,932,000. Invesco Ltd. grew its holdings in shares of Prestige Consumer Healthcare by 2.4% during the 4th quarter. Invesco Ltd. now owns 1,060,263 shares of the company's stock worth $82,796,000 after purchasing an additional 24,392 shares during the period. Finally, Congress Asset Management Co. increased its position in Prestige Consumer Healthcare by 5.0% during the 4th quarter. Congress Asset Management Co. now owns 908,742 shares of the company's stock worth $70,964,000 after purchasing an additional 43,619 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Up 0.8%

PBH traded up $0.65 during trading hours on Monday, reaching $85.71. 240,067 shares of the stock traded hands, compared to its average volume of 299,673. Prestige Consumer Healthcare Inc. has a fifty-two week low of $63.79 and a fifty-two week high of $90.04. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. The company has a market cap of $4.24 billion, a price-to-earnings ratio of 20.07, a PEG ratio of 2.69 and a beta of 0.45. The firm's fifty day simple moving average is $83.53 and its two-hundred day simple moving average is $82.50.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The company had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. During the same period last year, the firm earned $1.02 earnings per share. The company's revenue was up 7.0% on a year-over-year basis. As a group, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, May 17th. Oppenheimer lifted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a report on Thursday, February 13th. Finally, Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research report on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.